Back China Strategy

China: Latest Expectations for the Trump-Xi meeting

Published on October 29, 2025

∙ Download the PDF Report

By

Michael Hirson

Houze Song

President Trump and General Secretary Xi Jinping will meet at 11am Thursday local time in South Korea, 10pm ET Wednesday evening. Trump continues to surprise us with how quickly he has shifted into deal-making mode for this meeting, as we had expected the meeting to be something of a placeholder for a more ambitious visit to China in early Q1 (sometime before February 17).

Below is an update on our expectations for announcements/outcomes:

  • Reduction of fentanyl tariffs. Trump signaled in media comments that he expects to lower the 20% tariffs he imposed on Chinese imports to compel cooperation on fentanyl. We expect a commitment by Trump to lower tariffs by 10 percentage points. The effective date of the reduction could be soon, but may wait until Trump visits China early next year to show more evidence of stepped-up cooperation.
    • Caveats/Questions: The pending Supreme Court case against the IEEPA tariffs could remove this tariff authority, which may be one reason Trump is moving sooner than we expected.
  • Chinese purchases of US agriculture. US officials said over the weekend that China has committed to resume purchases of US soybeans and sorghum. The scale of soybean purchase commitments is unclear, but we assume that the baseline for US share in China’s market will be lower than the peak under the Phase One deal in 2021 (37% share). A reasonable baseline seems like a 25-30% share, with further upside likely dependent on a broader deal (perhaps when Trump visits China early next year).
    • Caveats/Questions: The experience of the Phase One deal was not positive for either side. It will be interesting to see whether this lowers the ambition of the purchase commitments in this deal.
  • Moving closer to resuming Nvidia chip exports. Trump also said that he plans to discuss Nvidia’s Blackwell chips with Xi, implying that he will encourage China to buy – and will allow Nvidia to sell – a chip designed for the China market that is more advanced than the H20 chips that Beijing has disdained. We have been expecting some upside for Nvidia chips in China, given that China’s domestic industry is capacity constrained.
    • Caveats/Questions: The geopolitics of tech competition makes this complicated for both sides. Beijing will not want to signal that it is flinging the doors wide open for Nvidia, given growing confidence in domestic chipmakers, so its messaging around allowing purchases of these chips – and perhaps the scale – may be subdued. For Trump, this would be a win for Nvidia and AMD, but it will incite considerable controversy in national security and AI circles. Allowing China access to Blackwell chips will improve the ability of Chinese AI companies to keep pace with US frontier models. There is a risk that Trump could reverse this decision down the road if tensions rise again.
  • Truce on rare earths and export controls. We expect China to suspend Document 61 (imposed on October 9) for one year as the key formal change in its rare earths regime, and more informally to agree to accelerate export approvals to US firms. The US will suspend or amend the “50% rule” announced on September 29.
    • Caveats/Questions: Details of what each side is offering here will be important, as previous agreements quickly broke down. Over the medium term, our special report last week (link HERE) noted that a truce will be fragile given the logic of US-China strategic competition and their respective efforts to have the upper hand in critical supply chain chokepoints.
  • Media reporting also suggests that Trump will agree to lower port fees on Chinese ships, recently imposed after a Section 301 investigation. The Chinese readout of trade talks over the weekend had earlier implied such a reduction was coming.
  • Finalization of a TikTok deal, though this might also wait until Trump’s visit to China.
  • Continued extension of the earlier US-China truce on tariffs, which was due for renewal on Nov. 10.
  • Potential upside for Chinese purchases of other US exports, such as Boeing planes. This is a good window for Beijing to build further momentum by dangling additional commitments.

We will have more to say about the US-China outlook following the meeting. Some of our questions:

  • What will be the political reaction in the US, given that Trump’s commitments weaken or even reverse some of his stated goals with China? As the Council on Foreign Relations’ Brad Setser notes on Twitter (link HERE), a 10 ppts reduction in tariffs on Chinese imports would put Trump’s second term increases on China tariffs at 20% — the same as Southeast Asian countries and only 5 ppts higher than Japan, South Korea, and the European Union.
  • What will be left to announce when Trump visits China early next year? A higher level of ambition for economic cooperation will increasingly come into tension with the broader dynamics of the US-China geopolitical rivalry. Beijing’s proposals for its next Five-Year Plan double-down on objectives and industrial policies – dominating advanced manufacturing, boosting self-reliance in critical technologies – that are of core concern to US policymakers (see our initial take HERE).
  • To what extent is Trump banking on Xi’s cooperation with Russia? We doubt Xi will do much to pressure Putin, leading to a risk of disappointment.

For China economic policy, the promise of tariff relief and stability on the US-China front further lowers the likelihood of additional near-term stimulus. The end-October Politburo meeting usually focuses on economic policies in Q4. But it is not clear that Beijing will hold a Politburo meeting this month, or that it will focus on the economy.

DISCLOSURES AND DISCLAIMERS

Analyst Certification

The analyst, 22V Research Group, primarily responsible for the preparation of this research report attests to the following: (1) that the views and opinions rendered in this research report reflect his or her personal views about the subject companies or issuers; and (2) that no part of the research analyst’s compensation was, is, or will be directly related to the specific recommendations or views in this research report.

Analyst Certifications and Independence of Research.

Each of the 22V Research analysts whose names appear on the front page of this report hereby certify that all the views expressed in this Report accurately reflect our personal views about any and all of the subject securities or issuers and that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views of in this Report.

22V Research (the “Company”) is an independent research provider. The Company is not a member of the FINRA or the SIPC and is not a registered broker dealer or investment adviser. 22V Research has no other regulated or unregulated business activities which conflict with its provision of independent research.

22V Research, LLC is a professional services and independent publication organization. 22V Research, LLC is not a securities broker-dealer, not a member of the Financial Industry Regulatory Authority (FINRA), not a registered investment advisor (RIA) and not a member of SIPC.

Securities transactions, when offered, are offered by 22V Securities, LLC through LPS Capital, LLC. Certain employees of 22V Securities, LLC are dually registered as securities representatives of LPS Capital, LLC or Analyst Hub Securities, LLC. 22V Securities, LPS Capital and Analyst Hub Securities are members FINRA, SIPC.

https://brokercheck.finra.org/

Current Ratings Definition.

SECTOR OUTPERFORM: An “outperform” rating anticipates the company will outperform the S&P Regional Banking Index (peer group).

SECTOR PERFORM: A “market perform” rating anticipates the company will perform in line with the S&P Regional Banking Index (peer group).

SECTOR UNDERPERFORM: An “underperform” rating anticipates the company will underperform the S&P Regional Banking Index (peer group).

Limitation Of Research And Information.

This Report has been prepared for distribution to only qualified institutional or professional clients of 22V Research Group. The contents of this Report represent the views, opinions, and analyses of its authors. The information contained herein does not constitute financial, legal, tax or any other advice. All third-party data presented herein were obtained from publicly available sources which are believed to be reliable; however, the Company makes no warranty, express or implied, concerning the accuracy or completeness of such information. In no event shall the Company be responsible or liable for the correctness of, or update to, any such material or for any damage or lost opportunities resulting from use of this data. Nothing contained in this Report or any distribution by the Company should be construed as any offer to sell, or any solicitation of an offer to buy, any security or investment. Any research or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of an overall portfolio strategy and you should consult with a professional financial advisor, legal and tax advisor prior to making any investment decision. 22V Research Group shall not be liable for any direct or indirect, incidental or consequential loss or damage (including loss of profits, revenue or goodwill) arising from any investment decisions based on information or research obtained from 22V Research Group.

Reproduction And Distribution Strictly Prohibited.

No user of this Report may reproduce, modify, copy, distribute, sell, resell, transmit, transfer, license, assign or publish the Report itself or any information contained therein. Notwithstanding the foregoing, clients with access to working models are permitted to alter or modify the information contained therein, provided that it is solely for such client’s own use. This Report is not intended to be available or distributed for any purpose that would be deemed unlawful or otherwise prohibited by any local, state, national or international laws or regulations or would otherwise subject the Company to registration or regulation of any kind within such jurisdiction.

Copyrights, Trademarks, Intellectual Property.

22V Research Group, and any logos or marks included in this Report are proprietary materials. The use of such terms and logos and marks without the express written consent of 22V Research Group is strictly prohibited. The copyright in the pages or in the screens of the Report, and in the information and material therein, is proprietary material owned by 22V Research Group unless otherwise indicated. The unauthorized use of any material on this Report may violate numerous statutes, regulations and laws, including, but not limited to, copyright, trademark, trade secret or patent laws.